InfaCare Pharmaceutical

InfaCare Pharmaceutical Corporation is engaged in the development of pharmaceuticals for the neonatal and pediatric patient population.

InfaCare Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and commercialization of pharmaceuticals for the neonatal and pediatric patient population. Its neonatal product, Stanate, is under development for the pharmacologic treatment of infantile jaundice or hyperbilirubinemia. The company was founded in 2005 and is based in Trevose, Pennsylvania.